Ignite Creation Date:
2024-05-06 @ 7:01 PM
Last Modification Date:
2024-10-26 @ 2:58 PM
Study NCT ID:
NCT05862272
Status:
RECRUITING
Last Update Posted:
2024-03-15
First Post:
2023-05-08
Brief Title:
A Phase 3B Study to Evaluate Bone Mineral Density with Long-Term Use of Relugolix Combination Tablet in Women with Uterine Fibroids or Endometriosis
Sponsor:
Sumitomo Pharma Switzerland GmbH
Organization:
Sumitomo Pharma Switzerland GmbH
Organization Data
Organization:
Sumitomo Pharma Switzerland GmbH
Class:
INDUSTRY
Study ID:
MVT-601A-006
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Sumitomo Pharma Switzerland GmbH
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None